• 1
    Achermann, P. & Borbély, A. A. Low frequency (< 1 Hz) oscillations in the human sleep electroencephalogram. Neuroscience, 1997, 81: 213 222.
  • 2
    Aeschbach, D., Cajochen, C., Landolt, H.-P., Borbély, A. A. Homeostatic sleep regulation in habitual short sleepers and long sleepers. Am. J. Physiol., 1996, 270: R41 R53.
  • 3
    Aeschbach, D., Dijk, D.-J., Trachsel, L., Brunner, D. P., Borbély, A. A. Dynamics of slow-wave activity and spindle frequency activity in the human sleep EEG. Effect of midazolam and zopiclone. Neuropsychopharmacology, 1994, 11: 237 244.
  • 4
    Benavides, J., Peny, B., Ruano, D., Vitorica, J., Scatton, B. Comparative autoradiographic distribution of central ω (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem. Brain Res., 1993, 604: 240 250.
  • 5
    Benington, J. H. & Heller, H. C. Restoration of brain energy metabolism as the function of sleep. Prog. Neurobiol., 1995, 45: 347 360.
  • 6
    Benington, J. H., Kodali, S. K., Heller, H. C. Stimulation of A1 adenosine receptors mimics the electroencephalographic effects of sleep deprivation. Brain Res., 1995, 692: 79 85.
  • 7
    Benoit, O., Bouard, G., Payan, C., Borderies, P., Prado, J. Effect of a single dose (10 mg) of zolpidem on visual and spectral analysis of sleep in young poor sleepers. Psychopharmacology, 1994, 116: 297 303.
  • 8
    Borbély, A. A., Baumann, F., Brandeis, D., Strauch, I., Lehmann, D. Sleep deprivation: effect on sleep stages and EEG power density in man. Electroenceph. Clin. Neurophysiol., 1981, 51: 483 493.
  • 9
    Borbély, A. A., Mattmann, P., Loepfe, M., Strauch, I., Lehmann, D. Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Human Neurobiol., 1985, 4: 189 194.
  • 10
    Brunner, D. P., Dijk, D.-J., Borbély, A. A. Repeated partial sleep deprivation progressively changes the EEG during sleep and wakefulness. Sleep, 1993, 16: 100 113.
  • 11
    Brunner, D. P., Dijk, D.-J., Münch, M., Borbély, A. A. Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology, 1991, 104: 1 5.
  • 12
    Cluydts, R., De Roeck, J., Cosyns, P., Lacante, P. Antagonizing the effects of experimentally induced sleep disturbance in healthy volunteers by lorazepam and zolpidem. J. Clin. Psychopharmacol., 1995, 15: 132 137.
  • 13
    Dennis, T., Dubois, A., Benavides, J., Scatton, B. Distribution of central ω1 (Benzodiazepine1) and ω2 (Benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the ω1 selective ligand [3H]zolpidem . J. Pharmacol. Exp. Ther., 1988, 247: 309 322.
  • 14
    Depoortere, H., Zivkovic, B., Lloyd, K. G., Sanger, D. J., Perrault, G., Langer, S. Z., Bartholini, G. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J. Pharmacol. Exp. Ther., 1986, 237: 649 658.
  • 15
    Dijk, D.-J., Beersma, D. G. M., Daan, S., van den Hoofdakker, R. H. Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur. J. Pharmacol., 1989, 171: 207 218.
  • 16
    Dijk, D.-J., Brunner, D. P., Borbély, A. A. Time course of EEG power density during long sleep in humans. Am. J. Physiol., 1990, 258: R650 R661.
  • 17
    Dijk, D.-J., Hayes, B., Czeisler, C. A. Dynamics of electroencephalographic sleep spindles and slow wave activity in men: Effect of sleep deprivation. Brain Res., 1993, 626: 190 199.
  • 18
    Endo, T., Roth, C., Landolt, H.-P., Werth, E., Aeschbach, D., Achermann, P., Borbély, A. A. Selective REM sleep deprivation in humans: effects on sleep and sleep EEG. Am. J. Physiol., 1998, 274: R1186 R1194.
  • 19
    Faulhaber, J., Steiger, A., Lancel, M. The GABAA agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans. Psychopharmacology, 1997, 130: 285 291.
  • 20
    Finelli, L. A., Landolt, H.-P., Buck, A., Roth, C., Berthold, T., Borbély, A. A., Achermann, P. Functional neuroanatomy of human sleep states after zolpidem and placebo: a H215O-PET study . J. Sleep Res., 2000, 9: 161 173.
  • 21
    Gaillard, J.-M. & Blois, R. Differential effects of flunitrazepam on human sleep in combination with flumazenil. Sleep, 1989, 12: 120 132.
  • 22
    Gillin, J. C., Buchsbaum, M. S., Vallandares-Neto, D. C., Hong, C. C.-H., Hazlett, E., Langer, S. Z., Wu, J. Effects of zolpidem on local cerebral glucose metabolism during non-REM sleep in normal volunteers: a positron emission tomography study. Neuropsychopharmacology, 1996, 15: 302 313.
  • 23
    Lancel, M., Faulhaber, J., Deisz, R. A. Effect of the GABA uptake inhibitor tiagabine on sleep and EEG power spectra in the rat. Br. J. Pharmacol., 1998, 123: 1471 1477.
  • 24
    Lancel, M., Faulhaber, J., Schiffelholz, T., Mathias, S., Deisz, R. A. Muscimol and midazolam do not potentiate each other’s effects on the sleep EEG in the rat. J. Neurophysiol., 1997, 77: 1624 1629.
  • 25
    Landolt, H.-P., Dijk, D.-J., Gaus, S. E., Borbély, A. A. Caffeine reduces low-frequency delta activity in the human sleep EEG. Neuropsychopharmacology, 1995a, 12: 229 238.
  • 26
    Landolt, H.-P., Werth, E., Borbély, A. A., Dijk, D.-J. Caffeine intake (200 mg) in the morning affects human sleep and EEG power spectra at night. Brain Res., 1995b, 675: 67 74.
  • 27
    Merlotti, L., Roehrs, T., Koshorek, G., Zorick, F., Lamphere, J., Roth, T. The dose effects of zolpidem on sleep of healthy normals. J. Clin. Psychopharmacol., 1989, 1: 9 14.
  • 28
    Niddam, R., Dubois, A., Scatton, B., Arbilla, S., Langer, S. Z. Autoradiographic localization of [3H]zolpidem binding sites in the rat CNS. Comparison with the distribution of [3H]flunitrazepam binding sites . J. Neurochem., 1987, 49: 890 899.
  • 29
    Rechtschaffen, A. & Kales, A. A manual of standardized terminology, techniques and scoring systems for sleep stages of human subjects. Public Health Service. US Government Printing Office, Washington D.C., 1968.
  • 30
    Roth, C., Achermann, P., Borbély, A. A. Alpha activity in the human REM sleep EEG. Topography and effect of REM sleep deprivation. Clin. Neurophysiol., 1999, 110: 1 4.
  • 31
    Roth, T., Roehrs, T., Vogel, G. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo. Sleep, 1995, 18: 246 251.
  • 32
    Ruano, D., Benavides, J., Machado, A., Vitorica, J. Regional differences in the enhancement by GABA of [3H]zolpidem binding to ω1 sites in rat brain membranes and sections. Brain Res., 1993, 600: 134 140.
  • 33
    Salvà, P. & Costa, J. Clinical pharmacokinetics and pharmacodynamics of zolpidem: therapeutic implications. Clin. Pharmacokinet., 1995, 29: 142 153.
  • 34
    Schwierin, B., Borbély, A. A., Tobler, I. Effects of N6-cyclopentyladenosine and caffeine on sleep regulation in the rat . Eur. J. Pharmacol., 1996, 300: 163 171.
  • 35
    Trachsel, L., Dijk, D.-J., Brunner, D. P., Klene, C., Borbély, A. A. Effect of zopiclone and midazolam on sleep and EEG spectra in a phase-advanced sleep schedule. Neuropsychopharmacology, 1990, 3: 11 18.
  • 36
    Walsh, J. K., Schweitzer, P. K., Sugerman, J. L., Muehlbach, M. J. Transient insomnia associated with a 3-hour phase advance of sleep time and treatment with zolpidem. J. Clin. Psychopharmacol., 1990, 10: 184 189.
  • 37
    Werth, E., Achermann, P., Borbély, A. A. Brain topography of the human sleep EEG. Antero-posterior shifts of spectral power. Neuroreport, 1996, 8: 123 127.
  • 38
    Werth, E., Achermann, P., Borbély, A. A. Fronto-occipital EEG power gradients in human sleep. J. Sleep Res., 1997, 6: 102 112.